AutoGenomics launches INFINITIŽ H. pylori Assay for detection of Helicobacter pylori and mutations at 2142G & 2143G that are associated with antibiotic resistance.
Lumenis Ltd., the world's largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will be supporting the first International Scar Treatment Conference in Israel, which will be held in Tel Aviv, on February 22nd, 2017.
In Support of the BLS Lymphoedema Awareness Week, PhysioPodŽ UK Ltd share the story of three year old Lincoln to raise awareness of both Primary Lymphoedema and DEEP OSCILLATIONŽ, a gentle, pleasant, non-invasive and effective treatment option, which is used in several NHS Lymphoedema Clinics and by private MLD DLT Practitioners.
SMi are thrilled to announce the release of the highly anticipated brochure for the 3rd In Vitro Diagnostics conference taking place on 14th & 15th of June in London.
SMi Group are delighted to welcome the expertise of Bakul Bhatnagar, Senior Principle Scientist- Biotherapeutics from Pfizer, when he presents two keynote addresses at Pharmaceutical Freeze Drying Technology taking place on 8th and 9th May 2017.
This study provides the first real-world evidence for the benefits of using the AerobikaŽ device in reducing exacerbation-related emergency department visits and hospital readmissions.
"Receiving recognition as one of America's Best Hospitals for Heart Care and Obstetrics by Women's Choice Awards is an incredible honor," said Robert T. Braithwaite, president and CEO of Hoag.
This latest study adds to the growing base of evidence that demonstrates Monaghan's drug-free AerobikaŽ device is effective for lung health maintenance.